Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: October 2015

Check-Cap Ltd. (CHEK) Starts Presentation at Dawson James Conference

Posted on October 15, 2015 by MissionIR

Check-Cap Ltd. (NASDAQ: CHEK) is a clinical stage medical diagnostics company leading the development of the first ingestible imaging capsule that utilizes low-dose X-rays for CRC screening. The Check-Cap device requires no bowel preparation or invasive procedures, and is designed … Continue reading →

Posted in Dawson James Conference | Leave a comment

Nephros, Inc. (NEPH) Starts Presentation at Dawson James Conference

Posted on October 15, 2015 by MissionIR

Nephros, Inc. (OTCBB: NEPH), a commercial stage medical device company, develops and sells high-performance liquid purification ultra-filters and an online mid-dilution hemodiafiltration system for use with a hemodialysis machine for the treatment of patients with end stage renal disease. Its … Continue reading →

Posted in Dawson James Conference | Leave a comment

TapImmune, Inc. (TPIV) Starts Presentation at Dawson James Conference

Posted on October 15, 2015 by MissionIR

TapImmune Inc. (OTCQB: TPIV) is an immunotherapy company specializing in the development of innovative technologies for the treatment of cancer and infectious diseases. The company’s peptide or nucleic acid-based immunotherapeutics comprise one or more naturally processed epitopes designed to comprehensively … Continue reading →

Posted in Dawson James Conference | Leave a comment

InspireMD, Inc. (NSPR) Starts Presentation at Dawson James Conference

Posted on October 15, 2015 by MissionIR

InspireMD, Inc. (NYSE: NSPR) was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio of embolic protection systems, which … Continue reading →

Posted in Dawson James Conference | Leave a comment

Cel-Sci Corp. (CVM) Starts Presentation at Dawson James Conference

Posted on October 15, 2015 by MissionIR

Cel-Sci Corp. (NYSE: CVM) aims to find the best way to activate the immune system to fight cancer and infectious diseases. The company’s lead investigational therapy, Multikine (Leukocyte Interleukin, Injection), is currently being studied in a pivotal phase 3 clinical … Continue reading →

Posted in Dawson James Conference | Leave a comment

Pulmatrix, Inc. (PULM) Starts Presentation at Dawson James Conference

Posted on October 15, 2015 by MissionIR

Pulmatrix, Inc. (NASDAQ: PULM) is developing innovative inhaled therapies to address serious pulmonary disease using its clinically validated, proprietary iSPERSE technology. Leveraging the unique capabilities of iSPERSE to dramatically advance inhalation technology, the company means to create new therapies to … Continue reading →

Posted in Dawson James Conference | Leave a comment

AxoGen, Inc. (AXGN) Starts Presentation at Dawson James Conference

Posted on October 15, 2015 by MissionIR

AxoGen, Inc. (NASDAQ: AXGN) is a medical technology company dedicated to peripheral nerve repair. The company’s portfolio of regenerative medicine products is available in the United States, Canada and several other countries and includes Avance® Nerve Graft, for bridging severed … Continue reading →

Posted in Dawson James Conference | Leave a comment

ContentChecked Holdings, Inc. (CNCK) Has Come Out Swinging in Aggressive Bid to Inform Consumers with Dietary Restrictions

Posted on October 15, 2015 by MissionIR

More than 15 million Americans, or roughly 4.7 percent of the population, live with the constant fear of a severe reaction to a type of food that could result in an allergic reaction. Every aisle in the grocery store and … Continue reading →

Posted in ContentChecked Holdings Inc. CNCK | Leave a comment

International Stem Cell Corp. (ISCO) to Present Comprehensive Findings for Parkinson’s Disease Program Preclinical Studies at Society for Neuroscience Annual Meeting

Posted on October 14, 2015 by MissionIR

International Stem Cell Corp., a California-based biotech company developing novel stem cell-based therapies and biomedical products, this morning said it will make an oral presentation on the comprehensive results of its preclinical development of human parthenogenetic neural stem cells (hPNSCs) … Continue reading →

Posted in International Stem Cell Corp. ISCO | Leave a comment

Oakridge Global Energy Solutions, Inc. (OGES) Stands Tall as the Only ‘Made in the USA’ Lithium-Ion Battery System Producer

Posted on October 14, 2015 by MissionIR

Global demand for lithium-ion batteries in on the rise, and the North American market is leading the charge. The United States currently ranks first in the world in terms of overall number of lithium-ion battery-based grid storage projects, and growing … Continue reading →

Posted in Oakridge Global Energy Solutions Inc. OGES | Leave a comment